Genus and The Roslin Institute Team Up to Produce PRRS-Resistant Pigs


By Jennifer Shike, FarmJournal's Pork 

October 5, 2021


Animal genetics company Genus and The Roslin Institute are pairing up to produce pigs that are resistant to the devastating respiratory disease – porcine reproductive and respiratory syndrome (PRRS). PRRS costs around $2.5 billion each year in the U.S. and Europe alone.


According to The Roslin Record, the two groups recently signed a licensing agreement in July. Researchers hope the agreement will lead the way to gene-edited, disease-resistant pigs becoming available to global pork-producing markets.


With the signing of this agreement, facilitated by Edinburgh Innovations, Genus will continue planned work for testing multiple generations of pigs and conducting studies required for FDA approval, the release said...